636 related articles for article (PubMed ID: 2471770)
41. Phenotype, cytotoxic, and helper functions of T cells from varicella zoster virus stimulated cultures of human lymphocytes.
Hayward A; Giller R; Levin M
Viral Immunol; 1989; 2(3):175-84. PubMed ID: 2483504
[TBL] [Abstract][Full Text] [Related]
42. Lymphokine production by human melanoma tumor-infiltrating lymphocytes.
Salmeron MA; Morita T; Seki H; Platsoucas CD; Itoh K
Cancer Immunol Immunother; 1992; 35(3):211-7. PubMed ID: 1386286
[TBL] [Abstract][Full Text] [Related]
43. Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens.
Wölfel T; Klehmann E; Müller C; Schütt KH; Meyer zum Büschenfelde KH; Knuth A
J Exp Med; 1989 Sep; 170(3):797-810. PubMed ID: 2788708
[TBL] [Abstract][Full Text] [Related]
44. Activation of autoreactive cytolytic T lymphocyte clone against human melanoma by anti-T3 monoclonal antibody and autologous accessory cells.
Tatake RJ; Guha A; Mukherji B
Cell Immunol; 1987 Aug; 108(1):42-52. PubMed ID: 3111724
[TBL] [Abstract][Full Text] [Related]
45. Multiple sub-sets of CD4+ and CD8+ cytotoxic T-cell clones directed to autologous human melanoma identified by cytokine profiles.
Maccalli C; Mortarini R; Parmiani G; Anichini A
Int J Cancer; 1994 Apr; 57(1):56-62. PubMed ID: 7908659
[TBL] [Abstract][Full Text] [Related]
46. Tumor-specific T-cell clones recognize different protein determinants of autologous human malignant melanoma cells.
Notter M; Schirrmacher V
Int J Cancer; 1990 May; 45(5):834-41. PubMed ID: 2159436
[TBL] [Abstract][Full Text] [Related]
47. Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells.
Zennadi R; Abdel-Wahab Z; Seigler HF; Darrow TL
Cell Immunol; 2001 Jun; 210(2):96-105. PubMed ID: 11520076
[TBL] [Abstract][Full Text] [Related]
48. Limited antitumor T cell response in melanoma patients vaccinated with interleukin-2 gene-transduced allogeneic melanoma cells.
Arienti F; Sulé-Suso J; Belli F; Mascheroni L; Rivoltini L; Melani C; Maio M; Cascinelli N; Colombo MP; Parmiani G
Hum Gene Ther; 1996 Oct; 7(16):1955-63. PubMed ID: 8930655
[TBL] [Abstract][Full Text] [Related]
49. Cellular immune response to human sarcomas: cytotoxic T cell clones reactive with autologous sarcomas. I. Development, phenotype, and specificity.
Slovin SF; Lackman RD; Ferrone S; Kiely PE; Mastrangelo MJ
J Immunol; 1986 Nov; 137(9):3042-8. PubMed ID: 3093588
[TBL] [Abstract][Full Text] [Related]
50. Acquisition of suppressive activity and natural killer-like cytotoxicity by human alloproliferative "helper" T cell clones.
Pawelec G; Schneider EM; Wernet P
J Immunol; 1986 Jan; 136(2):402-11. PubMed ID: 2934470
[TBL] [Abstract][Full Text] [Related]
51. Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition.
Pandolfi F; Boyle LA; Trentin L; Kurnick JT; Isselbacher KJ; Gattoni-Celli S
Cancer Res; 1991 Jun; 51(12):3164-70. PubMed ID: 1904004
[TBL] [Abstract][Full Text] [Related]
52. Human melanoma cells transfected with the B7-2 co-stimulatory molecule induce tumor-specific CD8+ cytotoxic T lymphocytes in vitro.
Imro MA; Dellabona P; Manici S; Heltai S; Consogno G; Bellone M; Rugarli C; Protti MP
Hum Gene Ther; 1998 Jun; 9(9):1335-44. PubMed ID: 9650618
[TBL] [Abstract][Full Text] [Related]
53. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
[TBL] [Abstract][Full Text] [Related]
54. Novel HLA-Cw8-restricted T cell epitopes derived from tyrosinase-related protein-2 and gp100 melanoma antigens.
Castelli C; Tarsini P; Mazzocchi A; Rini F; Rivoltini L; Ravagnani F; Gallino F; Belli F; Parmiani G
J Immunol; 1999 Feb; 162(3):1739-48. PubMed ID: 9973437
[TBL] [Abstract][Full Text] [Related]
55. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
Yasukawa M; Zarling JM
J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
[TBL] [Abstract][Full Text] [Related]
56. MHC-restricted recognition of autologous melanoma by tumor-specific cytotoxic T cells. Evidence for restriction by a dominant HLA-A allele.
Crowley NJ; Darrow TL; Quinn-Allen MA; Seigler HF
J Immunol; 1991 Mar; 146(5):1692-9. PubMed ID: 1671580
[TBL] [Abstract][Full Text] [Related]
57. T lymphocytes can mediate lysis of autologous melanoma cells by multiple mechanisms: evidence with a single T cell clone.
Mazzocchi A; Anichini A; Castelli C; Sensi M; Poli F; Russo C; Parmiani G
Cancer Immunol Immunother; 1990; 32(1):13-21. PubMed ID: 2149669
[TBL] [Abstract][Full Text] [Related]
58. Heterogeneity of clones from a human metastatic melanoma detected by autologous cytotoxic T lymphocyte clones.
Anichini A; Fossati G; Parmiani G
J Exp Med; 1986 Jan; 163(1):215-20. PubMed ID: 3484513
[TBL] [Abstract][Full Text] [Related]
59. Activation and function of an autoreactive T cell clone with dual immunoregulatory activity.
Kotani H; Mitsuya H; Benson E; James SP; Strober W
J Immunol; 1988 Jun; 140(12):4167-72. PubMed ID: 2453570
[TBL] [Abstract][Full Text] [Related]
60. CD4+ T cell clones isolated from human renal cell carcinoma possess the functional characteristics of Th2 helper cells.
Schoof DD; Terashima Y; Peoples GE; Goedegebuure PS; Andrews JV; Richie JP; Eberlein TJ
Cell Immunol; 1993 Aug; 150(1):114-23. PubMed ID: 8102084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
